| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |